Trinity Biotech Welcomes New Chief Commercial Officer
Trinity Biotech appoints Adrian Donohue as CCO, aiming for growth with new HIV product and CGM market entry.
- Latest
- Trending
Trinity Biotech appoints Adrian Donohue as CCO, aiming for growth with new HIV product and CGM market entry.
Jagdeep Singh, ChargePoint CCO, sells 9,389 shares at $1.3971 each to cover taxes, holding 886,364 shares, indicating confidence in company’s ...
Levi Strauss stock holds a Buy rating from UBS at a $25 target. Stable investor sentiment, strategic growth moves, and ...
Just Eat Takeaway partners with Amazon to offer free food delivery for Prime members in Germany, Austria, and Spain, starting ...
Enphase Energy EVP sells $600k in stock; Insider transactions may signal personal planning or insights into company’s future. Analyst updates ...
Deribit, the leading crypto options exchange, emphasizes its strong position in the market and the trust of its clients. The ...
Dyne Therapeutics appoints new CEO, George Eliades, and other key executives as it prepares for growth. Robert Coffin to step ...
OptiNose Inc. (OPTN) is a pharmaceutical company specializing in ear, nose, and throat treatments. Recent revenue was $70.99 million. Stock ...
Flutter Entertainment is launching a female-focused gaming product in the UK and Ireland, aiming to attract customers through social and ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.